Stockscreener 앱 받기
11.54
8.12%
-1.02
시간 외 거래:
11.55
0.01
+0.09%
전일 마감가:
$12.56
열려 있는:
$12.52
하루 거래량:
63,575
Relative Volume:
0.63
시가총액:
$990.39M
수익:
$106.66M
순이익/손실:
$15.16M
주가수익비율:
123.42
EPS:
0.0935
순현금흐름:
$6.37M
1주 성능:
-3.67%
1개월 성능:
+5.29%
6개월 성능:
-3.51%
1년 성능:
-18.33%
1일 변동 폭
$11.54
$12.73
1주일 범위
$11.54
$12.80
52주 변동 폭
$8.26
$26.37
Gyre Therapeutics Inc Stock (GYRE) Company Profile
명칭
Gyre Therapeutics Inc
전화
(619) 949-3681
주소
12770 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO
GYRE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GYRE
Gyre Therapeutics Inc
|
11.54 | 990.39M | 106.66M | 15.16M | 6.37M | 0.0935 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Gyre Therapeutics Inc Stock (GYRE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-04-29 | 재개 | Stephens | Overweight |
| 2021-02-10 | 개시 | Piper Sandler | Overweight |
| 2020-05-21 | 개시 | Raymond James | Outperform |
| 2019-01-04 | 개시 | Oppenheimer | Outperform |
| 2018-02-12 | 재확인 | B. Riley FBR, Inc. | Buy |
| 2018-02-09 | 재확인 | Chardan Capital Markets | Buy |
| 2017-12-08 | 개시 | B. Riley FBR, Inc. | Buy |
| 2017-06-12 | 개시 | Chardan Capital Markets | Buy |
| 2017-06-06 | 개시 | Ladenburg Thalmann | Buy |
| 2016-06-30 | 개시 | Rodman & Renshaw | Buy |
모두보기
Gyre Therapeutics Inc 주식(GYRE)의 최신 뉴스
Gyre Therapeutics president Ma Songjiang sells $49,380 in stock By Investing.com - Investing.com Australia
Gyre Therapeutics president Ma Songjiang sells $49,380 in stock - Investing.com
Gyre Therapeutics Faces Revenue Decline Amidst Future Prospects - TipRanks
Gyre therapeutics president Ma Songjiang sells $46,360 in stock - MSN
Gyre therapeutics president Ma Songjiang sells $45,434 in stock - MSN
Gyre therapeutics president Ma Songjiang sells $46,360 in stock By Investing.com - Investing.com Nigeria
Gyre Therapeutics, Inc. (NASDAQ:GYRE) President Songjiang Ma Sells 2,000 Shares - MarketBeat
Gyre Therapeutics president sells $45,380 in stock - MSN
Gyre therapeutics president Ma Songjiang sells $45,434 in stock By Investing.com - Investing.com Nigeria
Gyre Therapeutics president Ma Songjiang sells shares totaling $50,020 By Investing.com - Investing.com Australia
Gyre Therapeutics president Ma Songjiang sells shares totaling $50,020 - MSN
Insider Selling: Gyre Therapeutics, Inc. (NASDAQ:GYRE) President Sells 2,000 Shares of Stock - MarketBeat
Songjiang Ma Sells 2,000 Shares of Gyre Therapeutics, Inc. (NASDAQ:GYRE) Stock - Armenian Reporter
Gyre therapeutics president Ma Songjiang sells $48,029 in stock - MSN
Gyre therapeutics president Ma Songjiang sells $48,029 in stock By Investing.com - Investing.com Canada
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Short Interest Up 14.4% in January - MarketBeat
Gyre Therapeutics, Inc. (NASDAQ:GYRE) President Sells $22,360.00 in Stock - MarketBeat
Gyre Therapeutics president sells $45,380 in stock By Investing.com - Investing.com Australia
Gyre Therapeutics president Ma Songjiang sells $42,760 in stock - MSN
Gyre Therapeutics president Ma Songjiang sells $42,760 in stock By Investing.com - Investing.com Australia
Gyre Therapeutics president Ma Songjiang sells shares worth $42,960 By Investing.com - Investing.com Nigeria
Gyre Therapeutics president Ma Songjiang sells shares worth $42,960 - MSN
Barclays PLC Has $116,000 Stock Holdings in Gyre Therapeutics, Inc. (NASDAQ:GYRE) - Defense World
Gyre Therapeutics Inc (GYRE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.27%
3.05%
자본화:
|
볼륨(24시간):